Tower Research Capital LLC (TRC) - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 132 filers reported holding NOVAVAX INC in Q4 2013. The put-call ratio across all filers is 2.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2019$35,000
+3400.0%
63,667
+21336.7%
0.00%
Q4 2018$1,000
-96.4%
297
-98.0%
0.00%
-100.0%
Q3 2018$28,000
+21.7%
14,898
-14.2%
0.00%
+100.0%
Q2 2018$23,000
+53.3%
17,362
+148.7%
0.00%0.0%
Q1 2018$15,000
-6.2%
6,981
-45.9%
0.00%
-50.0%
Q4 2017$16,000
+700.0%
12,914
+659.6%
0.00%
Q1 2017$2,000
+100.0%
1,700
+240.0%
0.00%
Q4 2016$1,000
-87.5%
500
-66.1%
0.00%
-100.0%
Q1 2016$8,000
+166.7%
1,473
+223.0%
0.00%
Q3 2015$3,000
-95.5%
456
-92.3%
0.00%
-100.0%
Q2 2015$66,000
-54.2%
5,924
-65.9%
0.01%
-66.7%
Q1 2015$144,000
+1957.1%
17,383
+1480.3%
0.02%
+1700.0%
Q4 2014$7,000
-89.6%
1,100
-93.1%
0.00%
-87.5%
Q3 2014$67,000
+1575.0%
16,051
+1906.4%
0.01%
+700.0%
Q2 2014$4,000
-71.4%
800
-74.2%
0.00%
-50.0%
Q1 2014$14,000
-92.2%
3,100
-94.6%
0.00%
-89.5%
Q3 2013$180,00057,2890.02%
Other shareholders
NOVAVAX INC shareholders Q4 2013
NameSharesValueWeighting ↓
Caption Management, LLC 2,021,600$22,273,0001.23%
GREAT POINT PARTNERS LLC 4,500,000$2,479,0000.24%
SABBY MANAGEMENT, LLC 860,000$474,0000.23%
Sargent Investment Group, LLC 588,070$324,0000.16%
BB BIOTECH AG 8,330,000$4,589,0000.12%
GREAT POINT PARTNERS LLC 2,000,000$1,102,0000.11%
CENTAURUS FINANCIAL, INC. 7$12,000,0000.07%
Rock Springs Capital Management LP 3,250,000$1,790,0000.07%
Beirne Wealth Consulting Services, LLC 155,000$85,0000.07%
ACUTA CAPITAL PARTNERS, LLC 250,000$138,0000.07%
View complete list of NOVAVAX INC shareholders